3.89 -0.01 (-0.26%)

New 52W Low in past week

251.0K XNAS Volume

XNAS 17 Mar, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Voyager Therapeutics Inc is on 19 Mar 2025 for the purpose of Stifel 2025 Virtual CNS Forum See details


Insider Trading disclosures for Voyager Therapeutics Inc

The latest disclosure was made by Nathan Jorgensen in Voyager Therapeutics Inc where a trade of 103,000 Stock Option (Right to Buy) done was reported to US exchanges on Feb. 21, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Nathan Jorgensen Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2025 103,000 103,000 - - Stock Option (Right to Buy)
Nathan Jorgensen Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2025 51,500 131,500 (0%) 0% 0 Common Stock
Sandell Jacquelyn Fahey Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2025 41,500 123,143 (0%) 0% 0 Common Stock
Sandell Jacquelyn Fahey Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2025 83,000 83,000 - - Stock Option (Right to Buy)
Toby Ferguson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2025 63,000 168,000 (0%) 0% 0 Common Stock
Toby Ferguson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2025 126,000 126,000 - - Stock Option (Right to Buy)
Alfred W. Sandrock Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2025 145,000 441,816 (1%) 0% 0 Common Stock
Alfred W. Sandrock Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2025 290,000 290,000 - - Stock Option (Right to Buy)
Alfred W. Sandrock Director, President and CEO Sale of securities on an exchange or to another person at price $ 4.24 per share. 20 Feb 2025 11,702 296,816 (0%) 0% 4.2 49,616 Common Stock
Robin Swartz COO & CBO Sale of securities on an exchange or to another person at price $ 4.25 per share. 20 Feb 2025 3,894 98,397 (0%) 0% 4.3 16,550 Common Stock
Robin Swartz COO & CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2025 71,250 169,647 (0%) 0% 0 Common Stock
Robin Swartz COO & CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2025 142,500 142,500 - - Stock Option (Right to Buy)
Todd Carter Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 4.26 per share. 20 Feb 2025 3,305 77,718 (0%) 0% 4.3 14,079 Common Stock
Todd Carter Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2025 92,000 92,000 - - Stock Option (Right to Buy)
Todd Carter Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2025 46,000 123,718 (0%) 0% 0 Common Stock
Alfred W. Sandrock President & CEO Sale of securities on an exchange or to another person at price $ 4.45 per share. 11 Feb 2025 16,644 308,518 (0%) 0% 4.5 74,066 Common Stock
Robin Swartz COO & CBO Sale of securities on an exchange or to another person at price $ 4.45 per share. 11 Feb 2025 6,950 102,291 (0%) 0% 4.5 30,928 Common Stock
Todd Carter Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 4.45 per share. 11 Feb 2025 5,413 81,023 (0%) 0% 4.5 24,088 Common Stock
Sandell Jacquelyn Fahey Chief Legal Officer Sale of securities on an exchange or to another person at price $ 4.45 per share. 11 Feb 2025 4,358 81,643 (0%) 0% 4.4 19,393 Common Stock
Robin Swartz COO & CBO Sale of securities on an exchange or to another person at price $ 5.09 per share. 14 Jan 2025 3,087 109,241 (0%) 0% 5.1 15,713 Common Stock
Todd Carter Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 5.13 per share. 14 Jan 2025 1,191 86,436 (0%) 0% 5.1 6,110 Common Stock
Robin Swartz COO&CBO Sale of securities on an exchange or to another person at price $ 5.65 per share. 23 Dec 2024 6,500 112,328 (0%) 0% 5.7 36,725 Common Stock
Sandell Jacquelyn Fahey Chief Legal Officer Sale of securities on an exchange or to another person at price $ 5.82 per share. 02 Oct 2024 5,999 86,001 (0%) 0% 5.8 34,914 Common Stock
Nathan Jorgensen Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2024 80,000 80,000 (0%) 0% 0 Common Stock
Nathan Jorgensen Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jul 2024 200,000 200,000 - - Stock Option (Right to Buy)
James A. Geraghty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 24,000 24,000 - - Stock Option (Right to Buy)
George A. Scangos Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 24,000 24,000 - - Stock Option (Right to Buy)
Michael J. Higgins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 24,000 24,000 - - Stock Option (Right to Buy)
Glenn F. Pierce Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 24,000 24,000 - - Stock Option (Right to Buy)
Catherine J. Mackey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 24,000 24,000 - - Stock Option (Right to Buy)
Steven E. Hyman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 24,000 24,000 - - Stock Option (Right to Buy)
Grace E. Colon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 24,000 24,000 - - Stock Option (Right to Buy)
Nancy Vitale Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 24,000 24,000 - - Stock Option (Right to Buy)
Jude Onyia Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 24,000 24,000 - - Stock Option (Right to Buy)
Alfred W. Sandrock Director, President and CEO Sale of securities on an exchange or to another person at price $ 9.86 per share. 02 Apr 2024 12,115 322,839 (0%) 0% 9.9 119,454 Common Stock
Robin Swartz Chief Operating Officer Sale of securities on an exchange or to another person at price $ 9.88 per share. 02 Apr 2024 1,357 117,004 (0%) 0% 9.9 13,407 Common Stock
Toby Ferguson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2024 105,000 105,000 (0%) 0% 0 Common Stock
Toby Ferguson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2024 210,000 210,000 - - Stock Option (Right to Buy)
W. Alfred Sandrock Director, President and CEO Sale of securities on an exchange or to another person at price $ 7.46 per share. 21 Feb 2024 13,033 334,954 (0%) 0% 7.5 97,226 Common Stock
Peter Pfreundschuh P. Chief Financial Officer Sale of securities on an exchange or to another person at price $ 7.46 per share. 21 Feb 2024 3,764 175,669 (0%) 0% 7.5 28,079 Common Stock
Robin Swartz Chief Operating Officer Sale of securities on an exchange or to another person at price $ 7.45 per share. 21 Feb 2024 3,966 118,361 (0%) 0% 7.5 29,547 Common Stock
Todd Carter Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 7.47 per share. 20 Feb 2024 3,365 87,627 (0%) 0% 7.5 25,137 Common Stock
Carter Todd Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 7.68 per share. 20 Feb 2024 602 90,992 (0%) 0% 7.7 4,623 Common Stock
Fahey Sandell Jacquelyn Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2024 62,000 62,000 - - Stock Option (Right to Buy)
Todd Carter Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2024 77,000 77,000 - - Stock Option (Right to Buy)
W. Sandrock Alfred Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2024 260,000 260,000 - - Stock Option (Right to Buy)
Alfred W. Sandrock Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2024 130,000 347,987 (0%) 0% 0 Common Stock
Carter Todd Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2024 38,500 91,594 (0%) 0% 0 Common Stock
Robin Swartz Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2024 100,000 100,000 - - Stock Option (Right to Buy)
P. Peter Pfreundschuh Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2024 60,000 60,000 - - Stock Option (Right to Buy)
Sandell Fahey Jacquelyn Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2024 31,000 92,000 (0%) 0% 0 Common Stock
Swartz Robin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2024 50,000 122,327 (0%) 0% 0 Common Stock
Pfreundschuh P. Peter Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2024 30,000 179,433 (0%) 0% 0 Common Stock
Todd Carter Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 7.18 per share. 17 Jan 2024 1,266 53,094 (0%) 0% 7.2 9,090 Common Stock
Swartz Robin Chief Operating Officer Sale of securities on an exchange or to another person at price $ 7.15 per share. 17 Jan 2024 2,543 72,327 (0%) 0% 7.1 18,182 Common Stock
Sandell Jacquelyn Fahey Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jul 2023 122,000 122,000 - - Stock Option (Right to Buy)
Todd Carter Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 10.80 per share. 06 Jul 2023 5,500 59,860 (0%) 0% 10.8 59,400 Common Stock
Todd Carter Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2023 5,000 45,000 - - Stock Option (Right to Buy)
Todd Carter Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 11.41 per share. 30 Jun 2023 5,000 65,360 (0%) 0% 11.4 57,050 Common Stock
Todd Carter Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.85 per share. 30 Jun 2023 5,000 70,360 (0%) 0% 2.9 14,250 Common Stock
James A. Geraghty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 22,000 22,000 - - Stock Option (Right to Buy)
George A. Scangos Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 22,000 22,000 - - Stock Option (Right to Buy)
Michael J. Higgins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 22,000 22,000 - - Stock Option (Right to Buy)
Glenn F. Pierce Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 22,000 22,000 - - Stock Option (Right to Buy)
Catherine J. Mackey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 22,000 22,000 - - Stock Option (Right to Buy)
Steven E. Hyman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 22,000 22,000 - - Stock Option (Right to Buy)
Grace E. Colon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 22,000 22,000 - - Stock Option (Right to Buy)
Nancy Vitale Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 22,000 22,000 - - Stock Option (Right to Buy)
Jude Onyia Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 22,000 22,000 - - Stock Option (Right to Buy)
George A. Scangos Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2023 44,000 44,000 - - Stock Option (Right to Buy)
Alfred W. Sandrock Director, President and CEO Sale of securities on an exchange or to another person at price $ 7.83 per share. 03 Apr 2023 7,437 214,618 (0%) 0% 7.8 58,232 Common Stock
Robin Swartz Chief Operating Officer Sale of securities on an exchange or to another person at price $ 7.83 per share. 03 Apr 2023 1,259 71,617 (0%) 0% 7.8 9,858 Common Stock
Robert W. Hesslein Senior VP & General Counsel Sale of securities on an exchange or to another person at price $ 7.76 per share. 20 Mar 2023 4,410 102,200 (0%) 0% 7.8 34,222 Common Stock
Robin Swartz Chief Operating Officer Sale of securities on an exchange or to another person at price $ 7.76 per share. 20 Mar 2023 3,654 72,876 (0%) 0% 7.8 28,355 Common Stock
Todd Carter Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 7.76 per share. 20 Mar 2023 2,193 65,360 (0%) 0% 7.8 17,018 Common Stock
Robin Swartz Chief Operating Officer Sale of securities on an exchange or to another person at price $ 8.20 per share. 15 Mar 2023 15,373 76,530 (0%) 0% 8.2 126,059 Common Stock
Jude Onyia Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2023 44,000 44,000 - - Stock Option (Right to Buy)
Alfred W. Sandrock Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2023 120,000 222,055 (0%) 0% 0 Common Stock
Alfred W. Sandrock Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2023 240,000 240,000 - - Stock Option (Right to Buy)
Peter P. Pfreundschuh Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2023 76,000 76,000 - - Stock Option (Right to Buy)
Peter P. Pfreundschuh Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2023 38,000 163,000 (0%) 0% 0 Common Stock
Robert W. Hesslein Senior VP & General Counsel Sale of securities on an exchange or to another person at price $ 7.45 per share. 17 Feb 2023 3,297 106,610 (0%) 0% 7.5 24,563 Common Stock
Robin Swartz Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2023 80,000 80,000 - - Stock Option (Right to Buy)
Robin Swartz Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2023 40,000 91,903 (0%) 0% 0 Common Stock
Todd Carter Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2023 34,000 68,291 (0%) 0% 0 Common Stock
Todd Carter Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 7.45 per share. 17 Feb 2023 738 67,553 (0%) 0% 7.4 5,498 Common Stock
Todd Carter Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2023 68,000 68,000 - - Stock Option (Right to Buy)
Robert W. Hesslein Senior VP & General Counsel Sale of securities on an exchange or to another person at price $ 7.67 per share. 13 Feb 2023 2,868 109,907 (0%) 0% 7.7 21,998 Common Stock
Todd Carter Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 7.67 per share. 13 Feb 2023 797 34,291 (0%) 0% 7.7 6,113 Common Stock
Robert W. Hesslein Senior VP & General Counsel Sale of securities on an exchange or to another person at price $ 10.34 per share. 17 Jan 2023 792 112,775 (0%) 0% 10.3 8,189 Common Stock
Robert W. Hesslein Senior VP & General Counsel Sale of securities on an exchange or to another person at price $ 9.57 per share. 17 Jan 2023 1,396 113,567 (0%) 0% 9.6 13,360 Common Stock
Robin Swartz Chief Operating Officer Sale of securities on an exchange or to another person at price $ 9.57 per share. 17 Jan 2023 1,396 52,695 (0%) 0% 9.6 13,360 Common Stock
Robin Swartz Chief Operating Officer Sale of securities on an exchange or to another person at price $ 10.34 per share. 17 Jan 2023 792 51,903 (0%) 0% 10.3 8,189 Common Stock
Todd Carter Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 10.34 per share. 17 Jan 2023 400 35,088 (0%) 0% 10.3 4,136 Common Stock
Todd Carter Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 9.57 per share. 17 Jan 2023 706 35,488 (0%) 0% 9.6 6,756 Common Stock
Todd Carter Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 5.17 per share. 06 Jan 2023 388 36,582 (0%) 0% 5.2 2,006 Common Stock
Todd Carter Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 6.41 per share. 06 Jan 2023 388 36,194 (0%) 0% 6.4 2,487 Common Stock
Grace E. Colon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2023 44,000 44,000 - - Stock Option (Right to Buy)
Todd Carter Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2022 165,000 165,000 - - Stock Option (Right to Buy)
Catherine J. Mackey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2022 44,000 44,000 - - Stock Option (Right to Buy)
Michael J. Higgins Director Sale of securities on an exchange or to another person at price $ 6.70 per share. 14 Jul 2022 13,891 31,314 (0%) 0% 6.7 93,070 Common Stock
Glenn F. Pierce Director Sale of securities on an exchange or to another person at price $ 6.70 per share. 14 Jul 2022 9,512 16,788 (0%) 0% 6.7 63,730 Common Stock
James A. Geraghty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2022 22,000 22,000 - - Stock Option (Right to Buy)
Michael J. Higgins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2022 22,000 22,000 - - Stock Option (Right to Buy)
Glenn F. Pierce Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2022 22,000 22,000 - - Stock Option (Right to Buy)
Steven E. Hyman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2022 22,000 22,000 - - Stock Option (Right to Buy)
Nancy Vitale Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2022 22,000 22,000 - - Stock Option (Right to Buy)
Robert W. Hesslein Senior VP & General Counsel Sale of securities on an exchange or to another person at price $ 8.25 per share. 04 Apr 2022 2,786 114,963 (0%) 0% 8.3 22,985 Common Stock
Robin Swartz Chief Operating Officer Sale of securities on an exchange or to another person at price $ 8.25 per share. 04 Apr 2022 1,527 52,060 (0%) 0% 8.3 12,598 Common Stock
Alfred W. Sandrock Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Mar 2022 100,000 100,000 (0%) 0% 0 Common Stock
Alfred W. Sandrock Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Mar 2022 940,600 940,600 - - Stock Option (Right to Buy)
Robert W. Hesslein Senior VP & General Counsel Sale of securities on an exchange or to another person at price $ 8.29 per share. 21 Mar 2022 4,897 117,807 (0%) 0% 8.3 40,596 Common Stock
Robert W. Hesslein Senior VP & General Counsel Sale of securities on an exchange or to another person at price $ 8.67 per share. 21 Mar 2022 58 117,749 (0%) 0% 8.7 503 Common Stock
Julie Burek VP, Finance Sale of securities on an exchange or to another person at price $ 8.29 per share. 21 Mar 2022 2,618 52,489 (0%) 0% 8.3 21,703 Common Stock
Julie Burek VP, Finance Sale of securities on an exchange or to another person at price $ 8.68 per share. 21 Mar 2022 31 52,458 (0%) 0% 8.7 269 Common Stock
Robin Swartz Chief Operating Officer Sale of securities on an exchange or to another person at price $ 8.29 per share. 21 Mar 2022 4,362 53,638 (0%) 0% 8.3 36,161 Common Stock
Robin Swartz Chief Operating Officer Sale of securities on an exchange or to another person at price $ 8.69 per share. 21 Mar 2022 51 53,587 (0%) 0% 8.7 443 Common Stock
Robert W. Hesslein Senior VP & General Counsel Sale of securities on an exchange or to another person at price $ 3.55 per share. 17 Feb 2022 4,100 122,704 (0%) 0% 3.6 14,555 Common Stock
Julie Burek VP, Finance Sale of securities on an exchange or to another person at price $ 3.55 per share. 17 Feb 2022 789 55,107 (0%) 0% 3.6 2,801 Common Stock
Robert W. Hesslein Senior VP & General Counsel Sale of securities on an exchange or to another person at price $ 3.36 per share. 11 Feb 2022 3,252 126,804 (0%) 0% 3.4 10,927 Common Stock
Julie Burek VP, Finance Sale of securities on an exchange or to another person at price $ 3.36 per share. 11 Feb 2022 361 55,896 (0%) 0% 3.4 1,213 Common Stock
Alfred W. Sandrock Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2022 44,000 44,000 - - Stock Option (Right to Buy)
Robin Swartz Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2022 65,000 65,000 - - Stock Option (Right to Buy)
Michael J. Higgins Director, Interim President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2022 161,000 161,000 - - Stock Option (Right to Buy)
Michael J. Higgins Director, Interim President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2022 45,205 45,205 (0%) 0% 0 Common Stock
Glenn F. Pierce Director, Interim CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2022 26,300 26,300 (0%) 0% 0 Common Stock
Glenn F. Pierce Director, Interim CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2022 50,000 50,000 - - Stock Option (Right to Buy)
Robert W. Hesslein Senior VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2022 120,000 120,000 - - Stock Option (Right to Buy)
Robert W. Hesslein Senior VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2022 20,000 130,056 (0%) 0% 0 Common Stock
Julie Burek VP, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2022 10,000 56,257 (0%) 0% 0 Common Stock
Julie Burek VP, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2022 40,000 40,000 - - Stock Option (Right to Buy)
Julie Burek VP, Finance Sale of securities on an exchange or to another person at price $ 2.83 per share. 03 Jan 2022 3,063 46,522 (0%) 0% 2.8 8,668 Common Stock
Julie Burek VP, Finance Sale of securities on an exchange or to another person at price $ 3.06 per share. 03 Jan 2022 265 46,257 (0%) 0% 3.1 811 Common Stock
Julie Burek VP, Finance Grant, award, or other acquisition of securities at price $ 2.30 per share. 03 Jan 2022 3,063 49,585 (0%) 0% 2.3 7,045 Common Stock
Julie Burek VP, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Nov 2021 25,000 25,000 - - Stock Option (Right to Buy)
Julie Burek VP, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Nov 2021 13,500 46,522 (0%) 0% 0 Common Stock
Glenn Pierce Director, Interim CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2021 42,000 42,000 - - Stock Option (Right to Buy)
James A. Geraghty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2021 15,000 15,000 - - Stock Option (Right to Buy)
Mark J. Levin Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2021 15,000 15,000 - - Stock Option (Right to Buy)
Michael J. Higgins Director, Interim President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2021 115,000 115,000 - - Stock Option (Right to Buy)
Steven M. Paul Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2021 15,000 15,000 - - Stock Option (Right to Buy)
Glenn Pierce Director, Interim CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2021 50,000 50,000 - - Stock Option (Right to Buy)
Steven Hyman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2021 15,000 15,000 - - Stock Option (Right to Buy)
Nancy Vitale Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2021 15,000 15,000 - - Stock Option (Right to Buy)
Omar Khwaja See remarks Sale of securities on an exchange or to another person at price $ 4.03 per share. 21 May 2021 3,516 120,509 (0%) 0% 4.0 14,169 Common Stock
Robert W. Hesslein Senior VP & General Counsel Sale of securities on an exchange or to another person at price $ 4.95 per share. 05 Apr 2021 3,292 110,056 (0%) 0% 4.9 16,295 Common Stock
Robert W. Hesslein Senior VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2021 30,000 113,348 (0%) 0% 0 Common Stock
Allison Dorval Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2021 30,000 109,894 (0%) 0% 0 Common Stock
G. Andre Turenne Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2021 80,000 322,375 (0%) 0% 0 Common Stock
Omar Khwaja See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2021 35,000 124,025 (0%) 0% 0 Common Stock
Robert W. Hesslein Senior VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2021 68,000 68,000 - - Stock Option (Right to Buy)
Robert W. Hesslein Senior VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2021 34,000 83,348 (0%) 0% 0 Common Stock
Allison Dorval Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2021 34,000 79,894 (0%) 0% 0 Common Stock
Allison Dorval Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2021 68,000 68,000 - - Stock Option (Right to Buy)
G. Andre Turenne Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2021 94,000 242,375 (0%) 0% 0 Common Stock
G. Andre Turenne Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2021 189,000 189,000 - - Stock Option (Right to Buy)
Omar Khwaja See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2021 36,000 89,025 (0%) 0% 0 Common Stock
Omar Khwaja See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2021 72,000 72,000 - - Stock Option (Right to Buy)
Robert W. Hesslein Senior VP & General Counsel Sale of securities on an exchange or to another person at price $ 7.55 per share. 11 Feb 2021 3,186 49,348 (0%) 0% 7.5 24,054 Common Stock
Allison Dorval Chief Financial Officer Sale of securities on an exchange or to another person at price $ 7.55 per share. 11 Feb 2021 3,186 45,894 (0%) 0% 7.5 24,054 Common Stock
G. Andre Turenne Director, President & CEO Sale of securities on an exchange or to another person at price $ 7.55 per share. 11 Feb 2021 7,977 148,375 (0%) 0% 7.5 60,226 Common Stock
Omar Khwaja See remarks Sale of securities on an exchange or to another person at price $ 7.55 per share. 11 Feb 2021 3,475 53,025 (0%) 0% 7.5 26,236 Common Stock
Allison Dorval Chief Financial Officer Sale of securities on an exchange or to another person at price $ 8.62 per share. 12 Jan 2021 2,942 49,080 (0%) 0% 8.6 25,360 Common Stock
G. Andre Turenne Director, President & CEO Sale of securities on an exchange or to another person at price $ 8.62 per share. 12 Jan 2021 10,443 156,352 (0%) 0% 8.6 90,019 Common Stock
Nancy Vitale Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2020 30,000 30,000 - - Stock Option (Right to Buy)
James A. Geraghty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2020 15,000 15,000 - - Stock Option (Right to Buy)
Mark J. Levin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2020 15,000 15,000 - - Stock Option (Right to Buy)
Michael J. Higgins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2020 15,000 15,000 - - Stock Option (Right to Buy)
Steven M. Paul Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2020 15,000 15,000 - - Stock Option (Right to Buy)
Wendy L. Dixon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2020 15,000 15,000 - - Stock Option (Right to Buy)
Glenn Pierce Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2020 15,000 15,000 - - Stock Option (Right to Buy)
Steven Hyman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2020 15,000 15,000 - - Stock Option (Right to Buy)
Omar Khwaja See remarks Sale of securities on an exchange or to another person at price $ 12.96 per share. 21 May 2020 3,500 56,500 (0%) 0% 13.0 45,360 Common Stock
Robert W. Hesslein Senior VP & General Counsel Sale of securities on an exchange or to another person at price $ 8.51 per share. 03 Apr 2020 3,091 52,534 (0%) 0% 8.5 26,304 Common Stock
Robert W. Hesslein Senior VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2020 55,000 55,000 - - Stock Option (Right to Buy)
Robert W. Hesslein Senior VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2020 27,500 55,625 (0%) 0% 0 Common Stock
Allison Dorval Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2020 27,500 52,022 (0%) 0% 0 Common Stock
Allison Dorval Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2020 55,000 55,000 - - Stock Option (Right to Buy)
G. Andre Turenne Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2020 162,500 162,500 - - Stock Option (Right to Buy)
G. Andre Turenne Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2020 81,250 166,795 (0%) 0% 0 Common Stock
Omar Khwaja See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2020 30,000 60,000 (0%) 0% 0 Common Stock
Omar Khwaja See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2020 60,000 60,000 - - Stock Option (Right to Buy)
Allison Dorval Chief Financial Officer Sale of securities on an exchange or to another person at price $ 13.36 per share. 21 Jan 2020 3,128 24,522 (0%) 0% 13.4 41,790 Common Stock
Matthew P. Ottmer Chief Operating Officer Sale of securities on an exchange or to another person at price $ 13.36 per share. 21 Jan 2020 3,724 26,276 (0%) 0% 13.4 49,753 Common Stock
G. Andre Turenne Director, President & CEO Sale of securities on an exchange or to another person at price $ 13.36 per share. 21 Jan 2020 10,705 85,545 (0%) 0% 13.4 143,019 Common Stock
James A. Geraghty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 15,000 15,000 - - Stock Option (Right to Buy)
Mark J. Levin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 15,000 15,000 - - Stock Option (Right to Buy)
Michael J. Higgins None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 15,000 15,000 - - Stock Option (Right to Buy)
Steven M. Paul None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 15,000 15,000 - - Stock Option (Right to Buy)
Wendy L. Dixon None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 15,000 15,000 - - Stock Option (Right to Buy)
Perry A. Karsen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 15,000 15,000 - - Stock Option (Right to Buy)
Glenn Pierce None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 15,000 15,000 - - Stock Option (Right to Buy)
Steven Hyman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 15,000 15,000 - - Stock Option (Right to Buy)
Omar Khwaja See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2019 30,000 30,000 (0%) 0% 0 Common Stock
Omar Khwaja See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2019 170,000 170,000 - - Stock Option (Right to Buy)
Robert W. Hesslein Senior VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2019 28,125 28,125 (0%) 0% 0 Common Stock
Robert W. Hesslein Senior VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2019 168,750 168,750 - - Stock Option (Right to Buy)
Allison Dorval Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2019 25,000 26,106 (0%) 0% 0 Common Stock
Allison Dorval Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2019 50,000 50,000 - - Stock Option (Right to Buy)
Dinah Sah Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2019 50,000 50,000 - - Stock Option (Right to Buy)
Dinah Sah Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2019 25,000 163,688 (0%) 0% 0 Common Stock
Matthew P. Ottmer Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2019 60,000 60,000 - - Stock Option (Right to Buy)
Matthew P. Ottmer Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2019 30,000 30,000 (0%) 0% 0 Common Stock
G. Andre Turenne Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2019 96,250 96,250 (0%) 0% 0 Common Stock
G. Andre Turenne Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2019 192,500 192,500 - - Stock Option (Right to Buy)
Allison Dorval Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Nov 2018 45,000 45,000 - - Stock Option (Right to Buy)
Mark J. Levin Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 19 Sep 2018 1,500,000 6,391,176 (19%) 4% 0 Common Stock
Glenn Pierce None Purchase of securities on an exchange or from another person at price $ 18.44 per share. 12 Sep 2018 5,000 5,000 (0%) 0% 18.4 92,200 Common Stock
James A. Geraghty None Purchase of securities on an exchange or from another person at price $ 19.39 per share. 10 Sep 2018 3,000 76,588 (0%) 0% 19.4 58,170 Common Stock
James A. Geraghty None Purchase of securities on an exchange or from another person at price $ 18.31 per share. 17 Aug 2018 3,000 73,588 (0%) 0% 18.3 54,930 Common Stock
G. Andre Turenne Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jul 2018 650,000 650,000 - - Stock Option (Right to Buy)
Mark J. Levin Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 20 Jun 2018 1,500,000 7,891,176 (24%) 4% 0 Common Stock
James A. Geraghty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2018 15,000 15,000 - - Stock Option (Right to Buy)
Mark J. Levin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2018 15,000 15,000 - - Stock Option (Right to Buy)
Michael J. Higgins None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2018 15,000 15,000 - - Stock Option (Right to Buy)
Wendy L. Dixon None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2018 15,000 15,000 - - Stock Option (Right to Buy)
Perry A. Karsen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2018 15,000 15,000 - - Stock Option (Right to Buy)
Glenn Pierce None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2018 15,000 15,000 - - Stock Option (Right to Buy)
Steven Hyman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2018 15,000 15,000 - - Stock Option (Right to Buy)
Bernard Ravina Chief Medical Officer Sale of securities on an exchange or to another person at price $ 18.38 per share. 10 Apr 2018 2,451 0 (0%) 0% 18.4 45,049 Common Stock
Jane Pritchett Henderson Sr. V.P. & CFO, Corp. Dev. Sale of securities on an exchange or to another person at price $ 20.52 per share. 22 Mar 2018 11,200 0 (0%) 0% 20.5 229,824 Common Stock
Jane Pritchett Henderson Sr. V.P. & CFO, Corp. Dev. Sale of securities on an exchange or to another person at price $ 21.07 per share. 22 Mar 2018 19,900 0 (0%) 0% 21.1 419,293 Common Stock
Jane Pritchett Henderson Sr. V.P. & CFO, Corp. Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.97 per share. 22 Mar 2018 19,900 19,900 (0%) 0% 12.0 238,203 Common Stock
Jane Pritchett Henderson Sr. V.P. & CFO, Corp. Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Mar 2018 19,900 176,784 - - Stock Option (Right to Buy)
Jane Pritchett Henderson Sr. V.P. & CFO, Corp. Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Mar 2018 11,200 165,584 - - Stock Option (Right to Buy)
Jane Pritchett Henderson Sr. V.P. & CFO, Corp. Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.97 per share. 22 Mar 2018 11,200 11,200 (0%) 0% 12.0 134,064 Common Stock
Jane Pritchett Henderson CFO & SVP, Corp. Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.97 per share. 16 Mar 2018 15,416 15,416 (0%) 0% 12.0 184,530 Common Stock
Jane Pritchett Henderson CFO & SVP, Corp. Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2018 15,416 198,584 - - Stock Option (Right to Buy)
Jane Pritchett Henderson CFO & SVP, Corp. Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2018 1,900 196,684 - - Stock Option (Right to Buy)
Jane Pritchett Henderson CFO & SVP, Corp. Dev. Sale of securities on an exchange or to another person at price $ 21.76 per share. 16 Mar 2018 1,900 0 (0%) 0% 21.8 41,344 Common Stock
Jane Pritchett Henderson CFO & SVP, Corp. Dev. Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.97 per share. 16 Mar 2018 1,900 1,900 (0%) 0% 12.0 22,743 Common Stock
Jane Pritchett Henderson CFO & SVP, Corp. Dev. Sale of securities on an exchange or to another person at price $ 22.15 per share. 16 Mar 2018 15,416 0 (0%) 0% 22.1 341,464 Common Stock
Bernard Ravina Chief Medical Officer Sale of securities on an exchange or to another person at price $ 25.16 per share. 12 Mar 2018 2,451 2,451 (0%) 0% 25.2 61,667 Common Stock
Jane Pritchett Henderson Sr. V.P. & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2018 65,000 65,000 - - Stock Option (Right to Buy)
Steven M. Paul Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2018 110,000 110,000 - - Stock Option (Right to Buy)
Dinah Sah Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2018 65,000 65,000 - - Stock Option (Right to Buy)
Bernard Ravina Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2018 65,000 65,000 - - Stock Option (Right to Buy)
Matthew P. Ottmer Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2018 65,000 65,000 - - Stock Option (Right to Buy)
Dinah Sah Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. 27 Feb 2018 2,184 140,872 (0%) 0% 7.3 15,878 Common Stock
Dinah Sah Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2018 4,376 28,570 - - Stock Option (Right to Buy)
Dinah Sah Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 30.00 per share. 27 Feb 2018 15,623 138,688 (0%) 0% 30 468,690 Common Stock
Dinah Sah Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.83 per share. 27 Feb 2018 4,063 154,311 (0%) 0% 11.8 48,065 Common Stock
Dinah Sah Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.09 per share. 27 Feb 2018 5,000 150,248 (0%) 0% 11.1 55,450 Common Stock
Dinah Sah Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.33 per share. 27 Feb 2018 4,376 145,248 (0%) 0% 8.3 36,452 Common Stock
Dinah Sah Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2018 5,000 35,000 - - Stock Option (Right to Buy)
Dinah Sah Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2018 2,184 12,957 - - Stock Option (Right to Buy)
Dinah Sah Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2018 4,063 60,937 - - Stock Option (Right to Buy)
Bernard Ravina Chief Medical Officer Sale of securities on an exchange or to another person at price $ 18.24 per share. 12 Feb 2018 2,451 4,902 (0%) 0% 18.2 44,706 Common Stock
Bernard Ravina Chief Medical Officer Sale of securities on an exchange or to another person at price $ 16.40 per share. 10 Jan 2018 3,630 7,353 (0%) 0% 16.4 59,532 Common Stock
Bernard Ravina Chief Medical Officer Sale of securities on an exchange or to another person at price $ 13.63 per share. 11 Dec 2017 5,490 10,983 (0%) 0% 13.6 74,829 Common Stock
Bernard Ravina Chief Medical Officer Sale of securities on an exchange or to another person at price $ 13.26 per share. 10 Nov 2017 5,490 16,473 (0%) 0% 13.3 72,797 Common Stock
Bernard Ravina Chief Medical Officer Sale of securities on an exchange or to another person at price $ 20.33 per share. 10 Oct 2017 10,980 21,963 (0%) 0% 20.3 223,223 Common Stock
Matthew P. Ottmer Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Sep 2017 250,000 250,000 - - Stock Option (Right to Buy)
Bernard Ravina Chief Medical Officer Sale of securities on an exchange or to another person at price $ 10.00 per share. 05 Sep 2017 5,490 17,157 (0%) 0% 10 54,900 Common Stock
Bernard Ravina Chief Medical Officer Sale of securities on an exchange or to another person at price $ 14.30 per share. 20 Jul 2017 10,980 32,943 (0%) 0% 14.3 157,014 Common Stock
Bernard Ravina Chief Medical Officer Sale of securities on an exchange or to another person at price $ 10.00 per share. 20 Jul 2017 5,490 49,413 (0%) 0% 10 54,900 Common Stock
James A. Geraghty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2017 15,000 15,000 - - Stock Option (Right to Buy)
Mark J. Levin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2017 15,000 15,000 - - Stock Option (Right to Buy)
Michael J. Higgins None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2017 15,000 15,000 - - Stock Option (Right to Buy)
Wendy L. Dixon None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2017 15,000 15,000 - - Stock Option (Right to Buy)
Perry A. Karsen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2017 15,000 15,000 - - Stock Option (Right to Buy)
Glenn Pierce None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2017 15,000 15,000 - - Stock Option (Right to Buy)
Steven Hyman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2017 15,000 15,000 - - Stock Option (Right to Buy)
Mark J. Levin Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 12 Apr 2017 920,000 9,391,176 (36%) 3% 0 Common Stock
Steven M. Paul Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2017 240,000 240,000 - - Stock Option (Right to Buy)
Jane Pritchett Henderson Sr. V.P. & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2017 214,000 214,000 - - Stock Option (Right to Buy)
Wendy L. Dixon None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2017 30,000 30,000 - - Stock Option (Right to Buy)
Glenn Pierce None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2017 30,000 30,000 - - Stock Option (Right to Buy)
Robert Tepper Ten Percent Owner Other type of transaction at price $ 0.00 per share. 19 Dec 2016 750,000 10,311,176 - - Common Stock
Mark J. Levin Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 19 Dec 2016 750,000 10,311,176 - - Common Stock
James A. Geraghty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2016 15,000 15,000 - - Stock Option (Right to Buy)
Michael J. Higgins None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2016 15,000 15,000 - - Stock Option (Right to Buy)
Mark J. Levin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2016 15,000 15,000 - - Stock Option (Right to Buy)
Perry A. Karsen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2016 15,000 15,000 - - Stock Option (Right to Buy)
Steven Hyman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2016 15,000 15,000 - - Stock Option (Right to Buy)
Steven M. Paul Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2016 200,000 200,000 - - Stock Options (Right to Buy)
J. Jeffrey Goater Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2016 40,000 40,000 - - Stock Options (Right to Buy)
J. Jeffrey Goater Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2016 25,000 65,000 - - Stock Options (Right to Buy)
Steven M. Paul Director, President and CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Jan 2016 10,000 872,351 - - Common Stock
Robert Tepper Ten Percent Owner 16 Nov 2015 10,588,235 11,061,176 - - Common Stock
Robert Tepper Ten Percent Owner 16 Nov 2015 45,000,000 0 - - Series A Preferred Stock
Mark J. Levin None 16 Nov 2015 10,588,235 11,061,176 - - Common Stock
Mark J. Levin None 16 Nov 2015 45,000,000 0 - - Series A Preferred Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures